Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Navigating the Future of Shipping: Leadership Insights – Q2 2026
TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares
TEN Ltd. Announces Second LNG Carrier Order in Hyundai Heavy Industries
TEN Ltd. Declares Common Stock Dividend
Tsakos Energy Navigation: There Is Still Some Upside, But Investors Are Quite Cautious
TEN Ltd. Holds Its Thirty-Third Annual General Meeting of Shareholders
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
A Look at Tsakos Energy Navigation Ltd (TEN) After 5.2% Decline -- GF Value $22.21 vs Price $38.01
Tsakos Energy Navigation Limited (TEN) Q1 2026 Earnings Call Transcript
Tsakos Energy Navigation Q1 Earnings Call Highlights
TEN, Ltd. Reports Profits for First Quarter 2026 and Declares Second Semi-Annual Common Share Dividend of $1.00
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
TEN Ltd. Announces Date for the First Quarter 2026 Results, Conference Call and Webcast
Tsakos Energy Navigation Ltd (TEN) Shares Surge 4.2% -- What GF Score of 50 Tells Investors
TEN Ltd. Announces an Up to Five-Year Charter Extension of Two DP2 Shuttle Tankers
LNG Shipping Stocks: The Easing Of Tensions Led To A Decline
Tsakos Energy Navigation: Performing Well In Strong Markets
TEN Ltd. Announces Filing of Form 20-F with the SEC